Navigation Links
The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review
Date:11/22/2009

The Onder Law Firm’s attorneys are offering a free XOLAIR case review to those or families of those who may have experienced heart attack, stroke or other serious health problems after taking XOLAIR.

St. Louis, MO (Vocus) November 22, 2009 -- The Onder Law Firm are among attorneys offering free XOLAIR case review for serious health problems such as heart attack and stroke. The attorneys of the Onder Law Firm include experienced pharmaceutical litigation attorneys. The Onder Law Firm, which handles cases on a national basis, is quickly becoming a leader in large and complex litigation. A partner in the firm was recently appointed as co-lead counsel in the Yaz lawsuit filed in U.S. District Court for the Southern District of Illinois (MDL No. 2100).

The FDA is currently evaluating interim safety findings in an ongoing study of XOLAIR problems. XOLAIR (omalizumab) is an injected drug for asthma related allergies. The interim results of this study, which is being conducted by the drug’s manufacturer, Genentech, Inc., suggests an increased number of cardiovascular (heart attack) and cerebrovascular (stroke) adverse events in a group of patients using Xolair compared to a group of patients not given the drug (control group). The possible association has been identified based on interim results from an ongoing study of Xolair known as Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS). The results this study are not expected until 2012. Although the FDA and the drug manufacturer have not recalled XOLAIR, the FDA wants consumers to be aware of increased risks from taking XOLAIR, specifically heart attack/heart disease and stroke.

The Onder Law Firm, attorneys for XOLAIR cases, have launched a site that contains information regarding XOLAIR side effects and the rights those suffering from them may have. The attorneys of The Onder Law Firm will review will provide free XOLAIR case review to persons having experienced side effects or medical problems after taking the drug. The Onder Law Firm provides experienced legal representation without fee unless it collects for its clients.

About The Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States in pharmaceutical litigation such as Vioxx, Digitek, Ethex and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.onderlaw.com or call 1-877-ONDER-LAW.

# # #

Read the full story at http://www.prweb.com/releases/xolair/lawyers/prweb3244494.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Verdict One Releases Directory of Board Certified Attorneys for Consumers
2. Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione
3. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
4. Leventhal Weight Loss Incorporated Becomes First in the Nation Executive Weight Loss Consulting Service for Attorneys by an Attorney
5. Social Security Attorneys Prepare for Increased Baby Boomer SSI Claims
6. Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation
7. Social Security Attorneys Focus on Localized SEO Friendly Content
8. SumoBrain Adds Bulk PDF Downloading : Free Service Saves Money and Time for Attorneys, Inventors and Corporate IP Professionals
9. Cleveland Injury Attorneys Among 'The Best Lawyers in America'
10. Five Lubin & Meyer Lawyers Named Top Medical Malpractice Attorneys: Selected as Super Lawyers 2008
11. Jones Walker Attorneys Named to Positions in Order of British Crown
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review
(Date:8/23/2017)... ... August 23, 2017 , ... A new ... Orthopaedic Surgeons , points out that therapeutic modalities (physical therapy) is an important ... to the report, a wider scope of physical therapy options is showing promising ...
(Date:8/22/2017)... ... August 22, 2017 , ... The old adage ... as simple as eating healthy foods. But this well-known piece of nutrition advice ... or breaking apart carbohydrates—depends not only on properties of the food but also ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... solutions, announced recently the availability of a new professional fee E/M leveling calculator ... their service to the healthcare industry. E/M coding is complex which supports the ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Wilderness Voices”: a collection ... travel. “Wilderness Voices” is the creation of published author, Martha McKown, an ordained ... was inspired as a very young child when her older sisters studied High School ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... the Founder and Managing Member for t4 Leadership Development & Consulting. He has ... his definition of “success”: physician leadership development, servant leadership, data driven process improvement, ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Mostyn Law and Gulf Coast Regional Blood Center to host ... Mostyn Law family has had 3 members that needed ... Mostyn Law is partnering with Gulf Coast Regional Blood Center ... Blood supplies are running low. Gulf Coast Regional Blood Center,s ... August. That is why the blood center reached out to ...
(Date:8/15/2017)... Calif. , Aug. 15, 2017  AOTI Inc. announced today ... Oxygen Therapy Inc., has recently opened a New York City Office ... ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ) ... by the Accreditation Commission for Health Care (ACHC) under the company,s ... ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
Breaking Medicine Technology: